Burkitt Lymphoma

Diagnosis and Referral of Burkitt’s Lymphoma – 3 February 2023
Diagnosis and Referral of Burkitt’s Lymphoma – 3 February 2023 administrator 0 Views • 2 years ago

Introduction
SIOP CEDAR project, in a collaboration with International Pediatric Association (IPA), aims to improve the knowledge and understanding of general healthcare providers about the initial care of pediatric patients suspected of having cancer, and to provide information to help earlier diagnosis and referral of cases of pediatric cancer. This webinar included live expert talks, panel discussion followed by an interactive Q&A section.

Presenters
Case Scenario - Dr. Dr. Mangai Suseela (India)
When to suspect Burkitt Lymphoma? - Dr. Chantal Bouda (Burkina Faso)
Approach for diagnosis, initial management, and referral - Dr. Asim Belgaumi (Pakistan)

Panelists
Dr. Andishe Attarbaschi (Austria)
Dr. Monika Metzger (USA)
Dr. Murti Andriastuti (Indonesia)

Moderators
Dr. Claudia Sampor (Argentina)
Mr. Neil Ranasinghe (UK)
Dr. Aengus O’Marcaigh (Ireland)

Previous and forthcoming seminars
For more information about previous and forthcoming
seminars please go to
https://siop-online.org/cedar/

CEDAR Project
The SIOP Education and Training Committee is glad to announce the launch of the “Childhood Cancer Early Diagnosis and Appropriate Referral (CEDAR) project”, in collaboration with the International Pediatric Association (IPA). The main objective of the CEDAR Project is to improve the knowledge and understanding of general health care providers, including paediatricians, family practitioners, and community nurses, involved in the initial care, diagnostic workup, and referral of paediatric patients suspected of having cancer.

Practical Advice in monthly webinars
By providing practical advice from oncology experts from around the world, we aim to improve the outcomes of children with cancer in resource-limited settings where delayed diagnosis, misdiagnosis, and underdiagnosis significantly impact cancer-related morbidity and mortality. In the first phase of the CEDAR project, SIOP and IPA are organizing a series of monthly webinars (September 2022 to March 2023) to highlight the importance of early diagnosis, with a focus on the six WHO index cancers (acute lymphoblastic leukaemia, Hodgkin lymphoma, Burkitt’s lymphoma, Wilms tumour, retinoblastoma, and low-grade glioma). There will also be a discussion session with an international expert panel in each of these webinars.

Burkitt lymphoma made easy | Speedy Medical Hematology |
Burkitt lymphoma made easy | Speedy Medical Hematology | administrator 1 Views • 2 years ago

Burkitt lymphoma is a cancer of the lymphatic system, particularly B lymphocytes found in the germinal center. It is named after Denis Parsons Burkitt, the Irish surgeon who first described the disease in 1958 while working in equatorial Africa. The overall cure rate for Burkitt lymphoma in developed countries is about 90%, but worse in low-income countries. Burkitt lymphoma is uncommon in adults, where it has a worse prognosis

Burkitt lymphoma can be divided into three main clinical variants: the endemic, the sporadic, and the immunodeficiency-associated variants.

The endemic variant (also called "African variant") most commonly occurs in children living in malaria endemic regions of the world (e.g., equatorial Africa, Brazil, and Papua New Guinea).Epstein–Barr virus (EBV) infection is found in nearly all patients. Chronic malaria is believed to reduce resistance to EBV, allowing it to take hold. The disease characteristically involves the jaw or other facial bone, distal ileum, cecum, ovaries, kidney, or breast.
The sporadic type of Burkitt lymphoma (also known as "non-African") is the most common variant found in places where malaria is not holoendemic. The tumor cells have a similar appearance to the cancer cells of classical endemic Burkitt lymphoma. Sporadic lymphomas are rarely associated with the Epstein–Barr virus. Non-Hodgkin lymphoma, which includes Burkitt, accounts for 30–50% of childhood lymphoma. The jaw is less commonly involved, compared to the endemic variant. The ileocecal region is the common site of involvement.
Immunodeficiency-associated Burkitt lymphoma is usually associated with HIV infection or occurs in the setting of post-transplant patients who are taking immunosuppressive drugs. Burkitt lymphoma can be one of the diseases associated with the initial manifestation of AIDS.

Burkitt’s Lymphoma for the USMLE | HyGuru
Burkitt’s Lymphoma for the USMLE | HyGuru administrator 4 Views • 2 years ago

#USMLE #short

🔥 New Release! Check out my USMLE Step 1 Pass/Fail Course to help you Think Like the Test Maker:
https://hyguru.teachable.com/p..../usmle-step-1-pass-f

MY FREE #USMLE COURSES (you get a certificate at the end 😅):
🎓 USMLE #Step1 NBME Top Concepts:
https://hyguru.teachable.com/p..../hyguru-nbme-top-con ➡️ register with your .edu email!

Other Courses (paid):

⚖️ USMLE Principles of Productivity & Test Taking Strategies | Using Notion:
https://hyguru.teachable.com/p..../study-schedule-prod

Interested in personalized preparation? Visit ➡️ https://hyguru.com/private-tutoring/

CONNECT WITH ME:
💌 Sign up to my weekly email newsletter - https://www.hyguru.com
🌍 My website - https://www.hyguru.com
📸 Instagram - https://instagram.com/hyguruprep
🐦 Twitter - https://twitter.com/hyguruprep
💡 Facebook - https://facebook.com/hyguruprep

ABOUT ME
I am a pediatric critical care fellow passionate about inspiring the next generation of medical students. My goal is to deliver an active-recall based, engaging high-yield review so you rock your USMLE! I would love to connect with each and every one of you so definitely reach out!

Burkitt's Lymphoma Treatment NY | Clinical Trials | Cancer Center | Weill Cornell Lymphoma
Burkitt's Lymphoma Treatment NY | Clinical Trials | Cancer Center | Weill Cornell Lymphoma administrator 3 Views • 2 years ago

http://cornell-lymphoma.com/
After his diagnosis in January 2013, Adam Brock sought treatment for Burkitt’s Lymphoma at the Meyer Cancer Center at Weill Cornell Medical College and New York Presbyterian Hospital. As a young man, he was very worried that the experience of going through lymphoma cancer treatment would be a traumatizing one. The doctors at Weill Cornell gave Adam reassuring and compassionate care, and developed a successful lymphoma cancer treatment for him. The fact that the lymphoma treatment took place at one of the best hospitals in the world was extremely important for Adam, due to the fact that cancer patients usually have other urgent medical needs beyond the specific cancer treatment. The personal experience he had with his doctors and at the hospital itself proved crucial in helping him through the process. “It’s their passion, and they want to help people”. This was why Adam decided to be treated at Weill Cornell Medical College Lymphoma Program.

I was actually diagnosed with Stage IV Burkitt's Lymphoma back in January, 2013. When making the decision to go to Weill Cornell knowing that a general hospital was attached to it, that was by far a priority because through chemo there's so many other things that can happen to you. I was in the emergency room almost every single cycle because of my white blood count and it was the utmost important that I had connection to an ER or to another medical personnel. Going through chemo is a really traumatizing thing to go through, and you don't really know how bad it is until you're done with it. And it was just really good to know that they're not just there because it's their job, but they're there because it's their passion and they want to help people. I think it's really important when you're making any type of medical decision to do your research and knowing that Weill Cornell they're on the pulse of every single study out there. I think that's extremely important. Just knowing that my doctor was busy at conferences and going to present specific studies of strains of lymphoma and chemo regimens, that made me feel a lot better about myself and the treatment that I'm receiving here. Every hospital can go ahead and they can give you chemo, but it's about that personal connection that you feel with the medical staff and they know who I am. They know my likes, they know my dislikes, they know kind of like my ups and my downs, and what I need on a day to day basis and they follow up with me, and you really don't get that anywhere else. And I'm really happy that I was able to experience that here at Weill Cornell.

For more information on the Weill Cornell Medical College and their Lymphoma program, click the link below
http://youtu.be/8nonh_l8uzI

Lymphoma Cancer Treatment New York
Lymphoma Clinical Trials New York
Lymphoma Cancer Center New York
Lymphoma Symptoms NY
Lymphoma Cancer NY
CLL Treatment
Symptoms Of Lymphoma
Hodgkins Lymphoma
Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma Treatment
Lymphoma Treatment Options
Lymphoma Prognosis
What is Lymphoma
Alternative Lymphoma Cancer Treatment
Advanced Blood Cancer Treatment
Lymphoma Cancer Research
Lymphoma Clinical Trials Results

Video production, video search engine optimization and video marketing provided by Video SEO Pro, Inc. Generate more leads, more traffic to your website and more sales using video marketing. To learn more give us a call at (914) 368-9600 or click the link below.
http://www.myvideoseopro.com/lp001

Diagnosis and Referral of Burkitt’s Lymphoma – 3 February 2023
Diagnosis and Referral of Burkitt’s Lymphoma – 3 February 2023 administrator 3 Views • 2 years ago

Introduction
SIOP CEDAR project, in a collaboration with International Pediatric Association (IPA), aims to improve the knowledge and understanding of general healthcare providers about the initial care of pediatric patients suspected of having cancer, and to provide information to help earlier diagnosis and referral of cases of pediatric cancer. This webinar included live expert talks, panel discussion followed by an interactive Q&A section.

Presenters
Case Scenario - Dr. Dr. Mangai Suseela (India)
When to suspect Burkitt Lymphoma? - Dr. Chantal Bouda (Burkina Faso)
Approach for diagnosis, initial management, and referral - Dr. Asim Belgaumi (Pakistan)

Panelists
Dr. Andishe Attarbaschi (Austria)
Dr. Monika Metzger (USA)
Dr. Murti Andriastuti (Indonesia)

Moderators
Dr. Claudia Sampor (Argentina)
Mr. Neil Ranasinghe (UK)
Dr. Aengus O’Marcaigh (Ireland)

Previous and forthcoming seminars
For more information about previous and forthcoming
seminars please go to
https://siop-online.org/cedar/

CEDAR Project
The SIOP Education and Training Committee is glad to announce the launch of the “Childhood Cancer Early Diagnosis and Appropriate Referral (CEDAR) project”, in collaboration with the International Pediatric Association (IPA). The main objective of the CEDAR Project is to improve the knowledge and understanding of general health care providers, including paediatricians, family practitioners, and community nurses, involved in the initial care, diagnostic workup, and referral of paediatric patients suspected of having cancer.

Practical Advice in monthly webinars
By providing practical advice from oncology experts from around the world, we aim to improve the outcomes of children with cancer in resource-limited settings where delayed diagnosis, misdiagnosis, and underdiagnosis significantly impact cancer-related morbidity and mortality. In the first phase of the CEDAR project, SIOP and IPA are organizing a series of monthly webinars (September 2022 to March 2023) to highlight the importance of early diagnosis, with a focus on the six WHO index cancers (acute lymphoblastic leukaemia, Hodgkin lymphoma, Burkitt’s lymphoma, Wilms tumour, retinoblastoma, and low-grade glioma). There will also be a discussion session with an international expert panel in each of these webinars.

Showing 3 out of 3